Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
United Kingdom Emily Drabant Conley James Porter Prior To Federation Bio Nuvalent Inc Selection Of Next Development Candidates
Source: prnewswire.com